Fresh fund infusion by Munjals and Burmans may alter Fortis sale plans

The plan for fresh capital infusion (of Rs 12.50 billion) by Hero’s Munjals and Dabur’s Burmans has the potential to alter the entire deal scenario for Fortis Hospitals, such that the latter now has a scope to defer its sale altogether. 

Speaking to Business Standard, Sunil Kant Munjal, chairman, Hero Enterprise, said they are investing in Fortis for the long term.

“We do not do short-term investments. We think Fortis is a great asset and it both needs and deserves liquidity right now,” Munjal said. 

He added this is not only good from a shareholder’s point of view, but for